The ROE as of September 2024 (TTM) for Oncolytics Biotech Inc. (ONCY) is -114.55%

According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current ROE is -114.55%. This represents a change of 287.73% compared to the average of -29.54% of the last 4 quarters.

Oncolytics Biotech Inc. (ONCY) Historical ROE (quarterly & annually)

How has ONCY ROE performed in the past?

The mean historical ROE of Oncolytics Biotech Inc. over the last ten years is 4.11%. The current -114.55% ROE has changed -102.79% with respect to the historical average. Over the past ten years (40 quarters), ONCY's ROE was at its highest in in the December 2019 quarter at 17.98%. The ROE was at its lowest in in the June 2019 quarter at -138.70%.

Oncolytics Biotech Inc. (ONCY) ROE by Quarter and Year

Discovering the peaks and valleys of Oncolytics Biotech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncolytics Biotech Inc. (ONCY) Average ROE

How has ONCY ROE performed in the past?

The current ROE of Oncolytics Biotech Inc. (ONCY) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Oncolytics Biotech Inc. (ONCY) ROE vs. Peers

How is ONCY’s ROE compared to its peers?

Oncolytics Biotech Inc.’s ROE is greater than scPharmaceuticals Inc. (-201.84%), greater than Milestone Pharmaceuticals Inc. (-165.26%), less than Seres Therapeutics, Inc. (313.56%), greater than aTyr Pharma, Inc. (-56.83%), greater than DiaMedica Therapeutics Inc. (-38.56%), greater than Inhibikase Therapeutics, Inc. (-194.17%), less than X4 Pharmaceuticals, Inc. (0%), less than Galera Therapeutics, Inc. (32.93%), less than Terns Pharmaceuticals, Inc. (21.95%), greater than Day One Biopharmaceuticals, Inc. (-39.58%), greater than HOOKIPA Pharma Inc. (-122.70%), greater than CureVac N.V. (-51.77%), greater than Reata Pharmaceuticals, Inc. (-56.93%), less than Krystal Biotech, Inc. (19.32%), less than Vir Biotechnology, Inc. (13.36%), greater than Propanc Biopharma, Inc. (-30.93%), less than null (70.39%),

Build a custom stock screener for Oncolytics Biotech Inc. (ONCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncolytics Biotech Inc. (ONCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.